Document is current
Any future updates will be listed below
-
Authors
Xu, Jiajun
Chen, Gengshuo
Mo, Chune
Sha, Yu
Luo, Sha
Ou, Minglin https://orcid.org/0000-0001-7583-5190
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (20101020033)
Guangxi Natural Science Foundation (2024GXNSFAA010392)
Guangxi Medical and Health Key Cultivation Discipline Construction Project (Guangxi Medical and Health Key Cultivation Discipline Construction Project)
Guangxi Key Research and Development Plan (GuiKe AB24010096)
Guangxi Science and Technology Base and Talent Special Project (GuiKe AD24999032)
- License Information
-
More Information
Article History
Received: 30 July 2024
Accepted: 15 January 2025
First Online: 11 February 2025
Declarations
:
: The Ethics Committee of the Second Affiliated Hospital of Guilin Medical College approved the trial (NO.GZR-2020003) “The role and mechanism of CLCN7 ( R286W ) mediated TGF-β signaling pathway in osteopetrosis” on April 7, 2020. Written informed consent was obtained from patients or a legally designated representative. This clinical study was con‑ducted in full compliance with the Declaration of Helsinki.
: Not applicable.
: Authors state no conflict of interest.
